Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.

By D. Ehrmann, D. Liljenquist, K. Kasza, R. Azziz, R. Legro, M. Ghazzi. Journal of Clinical Endocrinology and Metabolism, 2006

699 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. (2012, background): “In the long term, overweight or obese women with PCOS had increased risk of developing metabolic syndrome, impaired glucose tolerance and type 2 diabetes (Legro et al., 1999; Ehrmann et al., 2006).”
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis (2011, background): “7 times more likely in women with PCOS with the highest versus the lowest BMI quartiles”
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. (2010, background): “Although the prevalence of MBS is high in PCOS, adjusting for BMI, it is lower if there is not excessive abdominal adiposity (66, 71).”
The metabolic syndrome. (2008, background): “Greater than two thirds of women with PCOS have some degree of glucose intolerance and are therefore at high risk for developing diabetes if they do not already have it (430, 435).”